The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
From Its 2026 Market Size, What Value Is The Hemostasis Diagnostic Devices And Equipment Market Projected To Reach By 2030?
The hemostasis diagnostic devices and equipment market has seen substantial growth in recent years. Its value is expected to rise from $5.66 billion in 2025 to $6.42 billion in 2026, representing a compound annual growth rate (CAGR) of 13.4%. This historical expansion is primarily due to factors such as an increase in bleeding disorder cases, the growing number of surgical procedures that require coagulation monitoring, the development of hospital laboratory services, the implementation of standardized clotting tests, and the availability of advanced coagulation reagents.
The hemostasis diagnostic devices and equipment market is projected to experience swift expansion in the upcoming years. By 2030, this market is anticipated to reach a valuation of $10.12 billion, exhibiting a compound annual growth rate (CAGR) of 12.0%. This projected growth during the forecast period is fueled by several factors, including the escalating demand for quick bedside diagnostics, the increasing embrace of AI-assisted coagulation analysis, the broadening scope of personalized anticoagulant therapy, rising capital expenditure in sophisticated laboratory infrastructure, and a heightened emphasis on preventive diagnostic methods. Key trends anticipated over the forecast timeframe encompass the expanding implementation of automated coagulation analyzers, a surging requirement for point-of-care hemostasis testing, the increasing incorporation of digital tools for result interpretation, the development of more extensive clotting analysis systems, and a sharpened focus on achieving quicker diagnostic turnaround times.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2598&type=smp
Which Important Drivers Are Guiding The Hemostasis Diagnostic Devices And Equipment Market Growth?
The increasing number of surgical procedures is anticipated to propel the growth of the hemostasis diagnostic devices and equipment market going forward. Surgical procedures encompass medical interventions or treatments that involve either making incisions or employing invasive techniques to access and treat internal or external body areas. This rise in surgical procedures is primarily attributed to the aging population, which consequently increases the prevalence of chronic and complex medical conditions necessitating surgical intervention. Hemostasis diagnostic devices significantly benefit surgical procedures by improving the management of blood clotting, minimizing risks, and enhancing overall surgical efficiency, ultimately leading to better patient outcomes. For instance, in April 2025, according to the British Broadcasting Corporation, a UK-based public service broadcaster, approximately 27,462 cosmetic surgical procedures were performed in 2024. This represented a 5 percent increase from 2023, with more than nine in ten procedures conducted on women. Consequently, the rising number of surgical procedures drives the growth of the hemostasis diagnostic devices and equipment market going forward.
How Are Segments Identified Within The Hemostasis Diagnostic Devices And Equipment Market Segment Framework?
The hemostasis diagnostic devices and equipment market covered in this report is segmented –
1) By Product: Analyzers, Coagulation Instrument, Other Hemostasis Instruments, Reagents and Kits
2) By Device Technology: Automated, Semi-Automated, Manual
3) By End User: Hospitals, Clinics, Independent Diagnostic, Laboratories, Other End Users
Subsegments:
1) By Analyzers: Hematology Analyzers, Platelet Function Analyzers, Thromboelastography (TEG) Analyzers
2) By Coagulation Instruments: Prothrombin Time (PT) Instruments, Activated Partial Thromboplastin Time (aPTT) Instruments, Fibrinogen Testing Instruments, Thrombin Time (TT) Instruments
3) By Other Hemostasis Instruments: Blood Clotting Time (BCT) Instruments, Bleeding Time (BT) Test Devices
4) By Reagents and Kits: Coagulation Reagents, Blood Collection Kits, Point-of-care Testing Kits, Thrombosis Kits
What Trends Are Influencing The Evolution Of The Hemostasis Diagnostic Devices And Equipment Market?
Leading companies in the hemostasis diagnostic devices and equipment market are concentrating on technological advancements, such as inhibitor-specific coagulation testing, to enhance patient safety, refine anticoagulation therapy, and lower the likelihood of bleeding or thrombotic events in individuals using direct oral anticoagulants (DOACs). These sophisticated tests empower laboratories and clinicians to precisely measure anticoagulant activity, guide dosage adjustments, and facilitate personalized therapy management. For example, in February 2024, Roche Diagnostics, a Switzerland-based manufacturer of diagnostic equipment and reagents for research and medical applications, introduced three new Factor Xa inhibitor coagulation tests for their cobas platforms. These tests are specifically engineered to quantify apixaban, rivaroxaban, and edoxaban activity in patient plasma samples. The objective of these tests is to provide swift, accurate, and dependable results to inform clinical decision-making in situations such as surgery, emergency care, or suspected bleeding complications. This product launch highlights the market’s progression towards personalized anticoagulation management, thereby improving safety and efficacy for patients receiving direct Factor Xa inhibitor therapy while also supplying laboratories with standardized, automated assay solutions.
Who Are The Companies Competing Within The Hemostasis Diagnostic Devices And Equipment Market?
Major companies operating in the hemostasis diagnostic devices and equipment market are Baxter International Inc., Johnson & Johnson, Abbott Laboratories, Beckman Coulter Inc., Becton Dickinson and Company, Chrono-Log Corporation, F. Hoffmann-La Roche Ltd., Grifols S.A., Siemens AG, Thermo Fisher Scientific Inc., Trinity Biotech plc., Ethicon Inc., B. Braun Interventional Systems Inc., Bio-Rad Laboratories Inc., CareFusion Corporation, Danaher Corporation, Diagnostica Stago SAS, Haemonetics Corporation, QuidelOrtho Corp, STAGO
Get The Full Hemostasis Diagnostic Devices And Equipment Market Report:
Which Region Represents The Largest Share Of The Hemostasis Diagnostic Devices And Equipment Market?
North America was the largest region in the global hemostasis diagnostic devices and equipment market in 2025. Asia-Pacific was the second-largest region in the hemostasis diagnostic devices and equipment market. The regions covered in the hemostasis diagnostic devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Hemostasis Diagnostic Devices And Equipment Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/customise?id=2598&type=smp
Browse Through More Reports Similar to the Global Hemostasis Diagnostic Devices And Equipment Market 2026, By The Business Research Company
Hematology Diagnostic Devices And Equipment Market Report 2026
Hemostasis Products Market Report 2026
https://www.thebusinessresearchcompany.com/report/hemostasis-products-global-market-report
Hematocrit Test Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/hematocrit-test-devices-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model